Background: Primary biliary cirrhosis (PBC) is an autoimmune liver disease
characterized by the destruction of intrahepatic small bile ducts. It is ge
nerally believed that cellular immune mechanisms, particularly T cells, cau
se this bile duct damage. CD30, which is inducible on selected T cells foll
owing activation, is regarded as important for B cell hyperactivity in seve
ral autoimmune diseases. In this study, we have attempted to examine CD30-e
xpressing lymphocytes in PBC with respect to B cell hyperactivity.
Methods: We surveyed and counted CD30(+) lymphocytes in liver sections from
13 patients with PBC and 36 control livers, including chronic viral hepati
tis, extrahepatic biliary obstruction and normal liver by immunohistochemic
al staining.
Results: Several CD30(+) lymphocytes were localized in inflamed portal trac
ts and also accentuated around the bile ducts in PBC livers, but they were
rarely detected in control liver sections. The numbers of CD30(+) lymphocyt
es in PBC were significantly higher than in control groups (P<0.01). Double
immunohistochemical staining revealed that these CD30(+) lymphocytes expre
ssed CD3 as well as CD4. The number of CD30(+) lymphocytes, moreover, corre
lated with that of immunoglobulin (Ig)A-containing cells (r= 0.72) in PBC,
although no such correlation between CD30(+) lymphocytes and IgM or IgG-con
taining cells was obtained.
Conclusions: These findings indicate that intrahepatic CD30(+) lymphocytes
have a role in IgA type, B cell abnormal hyperactivity with respect to the
pathogenesis of portal tract and bile duct lesions in PBC. (C) 1999 Blackwe
ll Science Asia Pty Ltd.